{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:08:43Z","timestamp":1790842123321,"version":"4.1.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Macrophages are one of the most common infiltrating immune cells and an essential component of tumor microenvironment. Macrophages and the soluble cytokines and chemokines produced play an important role in tumorigenesis, progression, invasion and metastasis in solid tumors. Despite the multiple studies in other solid tumors, there is little\u00a0known about macrophages in pituitary adenomas. Recently, studies about pituitary\u00a0adenoma-infiltrated macrophages have been emerging, including the immunohistochemical and immunophenotypic analysis of the pituitary adenomas and further studies into the mechanism of the crosstalk between macrophages and tumor cells<jats:italic>in vivo<\/jats:italic>and<jats:italic>in vitro<\/jats:italic>. These studies have offered us new insights into the polarization of macrophages and its role in tumorigenesis, progression and invasion of pituitary adenomas. This review describes the advances in the field of pituitary adenoma-infiltrated macrophages and the prospect of targeting macrophages as cancer therapy in pituitary adenoma.<\/jats:p>","DOI":"10.3389\/fendo.2021.785050","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T11:54:23Z","timestamp":1638446063000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches"],"prefix":"10.3389","volume":"12","author":[{"given":"Changxi","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe Bao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0144","article-title":"The Incidence Rate of Pituitary Adenomas in Western Sweden for the Period 2001-2011","volume":"171","author":"Tjornstrand","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0189","article-title":"The Epidemiology of Pituitary Adenomas in Iceland, 1955-2012: A Nationwide Population-Based Study","volume":"173","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-012-0454-0","article-title":"Prevalence and Incidence of Pituitary Adenomas: A Population Based Study in Malta","volume":"16","author":"Gruppetta","year":"2013","journal-title":"Pituitary"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3275\/760410.1007\/BF03347092","article-title":"Resistant Prolactinomas","volume":"34","author":"Vasilev","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the Treatment of Prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1270-8","article-title":"Management of Medically Refractory Prolactinoma","volume":"117","author":"Molitch","year":"2014","journal-title":"J Neuro-Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3171\/jns.2006.104.1.54","article-title":"Bromocriptine Treatment of Invasive Giant Prolactinomas Involving the Cavernous Sinus: Results of a Long-Term Follow Up","volume":"104","author":"Wu","year":"2006","journal-title":"J Neurosurg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000495775","article-title":"Management of Dopamine Agonist-Resistant Prolactinoma","volume":"109","author":"Maiter","year":"2019","journal-title":"Neuroendocrinology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-3019(00)00171-3","article-title":"Pituitary Adenomas: Results of 684 Surgically Treated Patients and Review of the Literature","volume":"53","author":"Oruckaptan","year":"2000","journal-title":"Surg Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1986.65.6.0733","article-title":"Pathology of Invasive Pituitary Tumors With Special Reference to Functional Classification","volume":"65","author":"Scheithauer","year":"1986","journal-title":"J\u00a0Neurosurg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000339823","article-title":"Natural History of Postoperative Nonfunctioning Pituitary Adenomas: A Systematic Review and Meta-Analysis","volume":"96","author":"Chen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.21037\/gs-20-873","article-title":"Diagnosis and Treatment of Refractory Pituitary Adenomas: A Narrative Review","volume":"10","author":"Liu","year":"2021","journal-title":"Gland Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13274","article-title":"Refractory Pituitary Adenoma: A Novel Classification for Pituitary Tumors","volume":"7","author":"Dai","year":"2016","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2703","article-title":"Innate and Adaptive Immune Cells in the Tumor Microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2020.01.031","article-title":"Tumor-Associated Macrophages","volume":"30","author":"Cassetta","year":"2020","journal-title":"Curr Biol: CB"},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-Associated Macrophages: From Mechanisms to Therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI84427","article-title":"The Impact of Hypoxia on Tumor-Associated Macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.09.016","article-title":"Metabolic Reprogramming Mediated by the Mtorc2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1937","article-title":"Macrophage Plasticity and Interaction With Lymphocyte Subsets: Cancer as a Paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1130","article-title":"Proteome Profiling of Cancer-Associated Fibroblasts Identifies Novel Proinflammatory Signatures and Prognostic Markers for Colorectal Cancer","volume":"19","author":"Torres","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jhep.2020.03.027","article-title":"Innate Immune Cells in Cirrhosis","volume":"73","author":"Bernsmeier","year":"2020","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"282ra47","DOI":"10.1126\/scitranslmed.aaa3230","article-title":"Vitamin D-Dependent Induction of Cathelicidin in Human Macrophages Results in Cytotoxicity Against High-Grade B Cell Lymphoma","volume":"7","author":"Bruns","year":"2015","journal-title":"Sci Transl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.05.022","article-title":"Cytotherapy With M1-Polarized Macrophages Ameliorates Liver Fibrosis by Modulating Immune Microenvironment in Mice","volume":"67","author":"Ma","year":"2017","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2421","article-title":"Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer","volume":"74","author":"Yeo","year":"2014","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI87252","article-title":"Tumor-Associated Macrophages Drive Spheroid Formation During Early Transcoelomic Metastasis of Ovarian Cancer","volume":"126","author":"Yin","year":"2016","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-007-9136-0","article-title":"Tumoral and Macrophage uPAR and MMP-9 Contribute to the Invasiveness of B16 Murine Melanoma Cells","volume":"25","author":"Marconi","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.01.014","article-title":"Production of Immune-Modulatory Nonclassical Molecules HLA-G and HLA-E by Tumor Infiltrating Ameboid Microglia\/Macrophages in Glioblastomas: A Role in Innate Immunity","volume":"220","author":"Kren","year":"2010","journal-title":"J Neuroimmunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgt305","article-title":"PD-1 Blockage Delays Murine Squamous Cell Carcinoma Development","volume":"35","author":"Belai","year":"2014","journal-title":"Carcinogenesis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1256","article-title":"Tumour-Educated Macrophages Promote Tumour Progression and Metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nm1093","article-title":"Specific Recruitment of Regulatory T Cells in Ovarian Carcinoma Fosters Immune Privilege and Predicts Reduced Survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-35","article-title":"Intratumoral Macrophages Contribute to Epithelial-Mesenchymal Transition in Solid Tumors","volume":"12","author":"Bonde","year":"2012","journal-title":"BMC Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01114-3","article-title":"Immune Profiling of Pituitary Tumors Reveals Variations in Immune Infiltration and Checkpoint Molecule Expression","volume":"24","author":"Mei","year":"2021","journal-title":"Pituitary"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa520","article-title":"Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion","volume":"105","author":"Principe","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s40478-019-0830-3","article-title":"Chemokines Modulate the Tumour Microenvironment in Pituitary Neuroendocrine Tumours","volume":"7","author":"Marques","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7150\/thno.53749","article-title":"Lactate-Induced M2 Polarization of Tumor-Associated Macrophages Promotes the Invasion of Pituitary Adenoma by Secreting CCL17","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-015-9383-6","article-title":"Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas","volume":"26","author":"Lu","year":"2015","journal-title":"Endocrine Pathol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03476-x","article-title":"In Silico Analysis of the Immunological Landscape of Pituitary Adenomas","volume":"147","author":"Yeung","year":"2020","journal-title":"J Neuro-Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26775","article-title":"Stratifying Nonfunctional Pituitary Adenomas Into Two Groups Distinguished by Macrophage Subtypes","volume":"10","author":"Yagnik","year":"2019","journal-title":"Oncotarget"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1993.tb01728.x","article-title":"Immunological Properties of TtT\/M-87 Cell Line Established From Murine Pituitary Tumor-Associated Macrophages","volume":"37","author":"Mitsuishi","year":"1993","journal-title":"Microbiol Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s13402-019-00453-z","article-title":"Tumor-Associated Macrophages: Role in Cancer Development and Therapeutic Implications","volume":"42","author":"Salmaninejad","year":"2019","journal-title":"Cell Oncol (Dordr)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0779-5","article-title":"Tumor Microenvironment Defines the Invasive Phenotype of AIP-Mutation-Positive Pituitary Tumors","volume":"38","author":"Barry","year":"2019","journal-title":"Oncogene"},{"key":"B42","article-title":"Epithelial-Mesenchymal Transition (EMT) Markers in Human Pituitary Adenomas Indicate a Clinical Course","volume":"35","author":"Jia","year":"2015","journal-title":"Anticancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/srep16965","article-title":"EZH2 is Highly Expressed in Pituitary Adenomas and Associated With Proliferation","volume":"5","author":"Schult","year":"2015","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of Pituitary Adenomas: A Community-Based, Cross-Sectional Study in Banbury (Oxfordshire, Uk)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s12020-020-02478-z","article-title":"The Role of the Tumour Microenvironment in the Angiogenesis of Pituitary Tumours","volume":"70","author":"Marques","year":"2020","journal-title":"Endocrine"},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.121.3.1206","article-title":"Separate Pathways of C Activation by Measles Virus Cytotoxic Antibodies: Subclass Analysis and Capacity of F(ab) Molecules to Activate C via the Alternative Pathway","volume":"121","author":"Ehrnst","year":"1978","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4081\/ejh.2019.3010","article-title":"VEGF, VEGF165b and EG-VEGF Expression Is Specifically Related With Hormone Profile in Pituitary Adenomas","volume":"63","author":"Corlan","year":"2019","journal-title":"Eur J Histochem: EJH"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30173","article-title":"Metalloproteinases ADAM12 and MMP-14 Are Associated With Cavernous Sinus Invasion in Pituitary Adenomas","volume":"139","author":"Wang","year":"2016","journal-title":"Int J Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-3515","article-title":"Matrix Metalloproteinases Contribute Distinct Roles in Neuroendocrine Prostate Carcinogenesis, Metastasis, and Angiogenesis Progression","volume":"70","author":"Littlepage","year":"2010","journal-title":"Cancer Res"},{"key":"B50","article-title":"Expression of Matrix Metalloproteinases in the Microenvironment of Spontaneous and Experimental Melanoma Metastases Reflects the Requirements for Tumor Formation","volume":"63","author":"Hofmann","year":"2003","journal-title":"Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-11-0433","article-title":"Matrix Metalloproteinase-9 Expression in Folliculostellate Cells of Rat Anterior Pituitary Gland","volume":"212","author":"Ilmiawati","year":"2012","journal-title":"J\u00a0Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/s1471-4906(02)02302-5","article-title":"Macrophage Polarization: Tumor-Associated Macrophages as a Paradigm for Polarized M2 Mononuclear Phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02638","article-title":"Activation of the IL-4\/STAT6 Signaling Pathway Promotes Lung Cancer Progression by Increasing M2 Myeloid Cells","volume":"10","author":"Fu","year":"2019","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-016-2564-x","article-title":"Identification of M2 Macrophages in Anterior Pituitary Glands of Normal Rats and Rats With Estrogen-Induced Prolactinoma","volume":"368","author":"Fujiwara","year":"2017","journal-title":"Cell Tissue Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa449","article-title":"The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness","volume":"105","author":"Wang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0874-6","article-title":"Pathogenesis of non-Functioning Pituitary Adenomas","volume":"21","author":"Zatelli","year":"2018","journal-title":"Pituitary"},{"key":"B57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/ERC-13-0043","article-title":"Aip Regulates cAMP Signalling and GH Secretion in GH3 Cells","volume":"20","author":"Formosa","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03636-z","article-title":"Comprehensive Analysis of the Immunological Landscape of Pituitary Adenomas: Implications of Immunotherapy for Pituitary Adenomas","volume":"149","author":"Zhou","year":"2020","journal-title":"J Neuro-Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180534","article-title":"Macrophages of Distinct Origins Contribute to Tumor Development in the Lung","volume":"215","author":"Loyher","year":"2018","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4185","article-title":"The Role of Microglia and Macrophages in Glioma Maintenance and Progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat Neurosci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now251","article-title":"Activation of CECR1 in M2-Like TAMs Promotes Paracrine Stimulation-Mediated Glial Tumor Progression","volume":"19","author":"Zhu","year":"2017","journal-title":"Neuro Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.isci.2018.10.011","article-title":"Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity","volume":"9","author":"Wallmann","year":"2018","journal-title":"iScience"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2020.1714209","article-title":"Autophagy-Dependent Ferroptosis Drives Tumor-Associated Macrophage Polarization via Release and Uptake of Oncogenic KRAS Protein","volume":"16","author":"Dai","year":"2020","journal-title":"Autophagy"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-017-0648-1","article-title":"ROS Signaling Under Metabolic Stress: Cross-Talk Between AMPK and AKT Pathway","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(99)80026-0","article-title":"Folliculo-Stellate Cells in Pituitary Adenomas of Patients With Acromegaly","volume":"195","author":"Voit","year":"1999","journal-title":"Pathol Res Pract"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00003.2011","article-title":"Cellular and Molecular Specificity of Pituitary Gland Physiology","volume":"92","author":"Perez-Castro","year":"2012","journal-title":"Physiol Rev"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-2-20","article-title":"Folliculo-Stellate Cells of \u201cTrue Dendritic\u201d Type are Involved in the Inflammatory Microenvironment of Tumor Immunosurveillance of Pituitary Adenomas","volume":"2","author":"Vajtai","year":"2007","journal-title":"Diagn Pathol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27681","article-title":"Extracellular Matrix (ECM) Stiffness and Degradation as Cancer Drivers","volume":"120","author":"Najafi","year":"2019","journal-title":"J Cell Biochem"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83871","article-title":"Cancer Immunotherapy: Harnessing the Immune System to Battle Cancer","volume":"125","author":"Yang","year":"2015","journal-title":"J Clin Invest"},{"key":"B71","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2017.261","article-title":"Inhibition of Colony Stimulating Factor-1 Receptor Abrogates Microenvironment-Mediated Therapeutic Resistance in Gliomas","volume":"36","author":"Yan","year":"2017","journal-title":"Oncogene"},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9885","article-title":"Targeted Gene Silencing of CCL2 Inhibits Triple Negative Breast Cancer Progression by Blocking Cancer Stem Cell Renewal and M2 Macrophage Recruitment","volume":"7","author":"Fang","year":"2016","journal-title":"Oncotarget"},{"key":"B73","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2010.07.044","article-title":"Anti-CD47 Antibody Synergizes With Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma","volume":"142","author":"Chao","year":"2010","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-12-3058","article-title":"Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment","volume":"73","author":"Le Mercier","year":"2013","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20171435","article-title":"Myeloid-Targeted Immunotherapies Act in Synergy to Induce Inflammation and Antitumor Immunity","volume":"215","author":"Perry","year":"2018","journal-title":"J Exp Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nature21409","article-title":"Class IIa HDAC Inhibition Reduces Breast Tumours and Metastases Through Anti-Tumour Macrophages","volume":"543","author":"Guerriero","year":"2017","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nature19834","article-title":"Pi3k\u03b3 is a Molecular Switch That Controls Immune Suppression","volume":"539","author":"Kaneda","year":"2016","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a021857","article-title":"CSF-1 Receptor Signaling in Myeloid Cells","volume":"6","author":"Stanley","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.193","article-title":"Therapeutic Effects of CSF1R-Blocking Antibodies in Multiple Myeloma","volume":"32","author":"Wang","year":"2018","journal-title":"Leukemia"},{"key":"B80","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-020-01165-x","article-title":"CCL2-CCR2 Axis Recruits Tumor Associated Macrophages to Induce Immune Evasion Through PD-1 Signaling in Esophageal Carcinogenesis","volume":"19","author":"Yang","year":"2020","journal-title":"Mol Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1604268113","article-title":"Durable Antitumor Responses to CD47 Blockade Require Adaptive Immune Stimulation","volume":"113","author":"Sockolosky","year":"2016","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1012501","article-title":"TLR Agonists: Our Best Frenemy in Cancer Immunotherapy","volume":"93","author":"Kaczanowska","year":"2013","journal-title":"J Leukocyte Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.02.003","article-title":"Targeting Tumor-Associated Macrophages in Cancer","volume":"40","author":"Pathria","year":"2019","journal-title":"Trends Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting Macrophages: Therapeutic Approaches in Cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-01003-4","article-title":"Common Tools for Pituitary Adenomas Research: Cell Lines and Primary Cells","volume":"23","author":"Zhu","year":"2020","journal-title":"Pituitary"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.785050\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T22:58:11Z","timestamp":1673909891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.785050\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":85,"alternative-id":["10.3389\/fendo.2021.785050"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.785050","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"article-number":"785050"}}